Ferring International Center opens for business
in TIMELINES on
On January 1st the new Ferring International Center building in Ørestad, Copenhagen opened for business. With its 20 floors, designed…
0
0
-
Read more
-
5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)
in PRESS RELEASE 2002 onRead moreMore evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…
-
Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement
in PRESS RELEASE 2002 onRead moreCOPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…
-
Ferring and Johnson & Johnson Join in a Research Collaboration
in PRESS RELEASE 2002 onRead moreFerring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…
-
Ferring appoints new Board member
in PRESS RELEASE 2002 onRead moreThe Board of Directors of Ferring announced this week that Professor Michael Rosenblatt has been appointed to the Group Board…
-
Ferring Appoints New Vice-President of Global Marketing
in PRESS RELEASE 2002 onRead moreFerring would like to announce that Mr. Aaron Graff has been appointed as Vice President of Global Marketing, Medical Services and Business Development…
-
Taking the Needle Out of the Injection
in PRESS RELEASE 2002 onRead moreFerring Launches a New No Needle Device at 2nd Ferring International Paediatric Endocrinology Symposium…
-
Ferring Appoints New Board Member
in PRESS RELEASE 2002 onRead moreThe Board of Directors of Ferring announced today that Mr. Bernd Wolff has been appointed as a board member. Wolff becomes an outside director to the board…
-
FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified)
in PRESS RELEASE 2002 onRead moreFerring Pharmaceuticals, a world leader in naturally occurring protein hormones, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Bravelle™…
-
Building for the 21st Century
in PRESS RELEASE 2002 onRead moreThe new Ferring International Center in Copenhagen will be officially inaugurated by the Danish Minister for Science, Technology and Innovation and renowned architect Henning Larsen on Thursday, March 21st, 2002…